Knopp Biosciences Completes Class C Financing and Elects David Adair to Board of Managers
Recent financings position Knopp to reach 2021 milestones in eosinophilic asthma and rare pediatric epilepsy PITTSBURGH, PA, NOVEMBER 11, 2020—Knopp Biosciences LLC today announced that it had completed a Class C equity financing of approximately $14 million led by Solas … Continued